Search

Niels Borgstein Phones & Addresses

  • Medfield, MA
  • Marlboro, VT
  • Wardsboro, VT
  • Guilford, VT
  • 2 Larchwood Ln, East Lyme, CT 06333 (860) 739-7430
  • New London, CT
  • 86 Plain St, Medfield, MA 02052

Work

Position: Food Preparation and Serving Related Occupations

Education

Degree: High school graduate or higher

Resumes

Resumes

Niels Borgstein Photo 1

Group Head At Millennium Pharmaceuticals

View page
Position:
Group Head, Oncology Clinical Research at Millennium Pharmaceuticals, Senior Medical Director, Global Clinical Leader at Millennium Pharmaceuticals, BioPharmaceutical Clinical Consultant at BBC Consulting
Location:
Greater Boston Area
Industry:
Biotechnology
Work:
Millennium Pharmaceuticals - Cambridge, MA since Aug 2011
Group Head, Oncology Clinical Research

Millennium Pharmaceuticals since Feb 2011
Senior Medical Director, Global Clinical Leader

BBC Consulting since 2010
BioPharmaceutical Clinical Consultant

Acceleron Pharma 2007 - 2010
Vice President, Medical Research

Stryker Biotech 2006 - 2007
Senior Director
Education:
University of Groningen 1982 - 1990
Skills:
Life Sciences
Oncology
Clinical Trials
Clinical Development
Clinical Research
Languages:
Dutch
Chichewa
Niels Borgstein Photo 2

Vice President, Head Of Clinical Development At Ironwood Pharmaceuticals

View page
Location:
86 Plain St, Medfield, MA 02052
Industry:
Pharmaceuticals
Work:
Millennium Pharmaceuticals - Cambridge, MA since Aug 2011
Group Head, Oncology Clinical Research

Millennium Pharmaceuticals since Feb 2011
Senior Medical Director, Global Clinical Leader

BBC Consulting since 2010
BioPharmaceutical Clinical Consultant

Acceleron Pharma 2007 - 2010
Vice President, Medical Research

Stryker Biotech 2006 - 2007
Senior Director
Education:
University of Groningen 1982 - 1990
Skills:
Clinical Development
Clinical Trials
Drug Development
Clinical Research
Oncology
Cancer
Medicine
Urology
Biotechnology
Pharmaceutical Industry
Life Sciences
Biopharmaceuticals
Lifesciences
Gcp
Pharmacology
Cro
Languages:
Dutch
English

Business Records

Name / Title
Company / Classification
Phones & Addresses
Niels Borgstein
Vice-President
Acceleron Pharma
Biotechnology · Whol Drugs/Sundries · Research & Development in Biotechnology
128 Sidney St, Cambridge, MA 02139
149 Sidney St, Cambridge, MA 02139
(617) 649-9200, (617) 649-9988, (617) 576-2220, (617) 576-2224

Publications

Us Patents

Methods For Dosing An Activin-Actriia Antagonist And Monitoring Of Treated Patients

View page
US Patent:
20100015144, Jan 21, 2010
Filed:
Jun 26, 2009
Appl. No.:
12/459202
Inventors:
Matthew L. Sherman - Newton MA, US
Niels Borgstein - Medfield MA, US
Assignee:
Acceleron Pharma Inc. - Cambridge MA
International Classification:
A61K 39/395
C12Q 1/02
G01N 33/20
A61K 38/16
G01N 33/72
G01N 33/68
A61P 19/08
A61P 35/00
A61B 5/021
US Classification:
4241341, 435 29, 436 84, 514 12, 436 66, 436 86, 4241581, 600485
Abstract:
In certain aspects, the present invention provides methods for dosing a patient with an activin-ActRIIa antagonist and methods for managing patients treated with an activin-ActRIIa anatagonist. In certain aspects, the methods involve measuring one or more hematologic parameters in a patient.

Antagonists Of Activin-Actriia And Uses For Increasing Red Blood Cell Levels

View page
US Patent:
20100028331, Feb 4, 2010
Filed:
Jun 26, 2009
Appl. No.:
12/459188
Inventors:
Matthew L. Sherman - Newton MA, US
Jasbir Seehra - Lexington MA, US
Niels Borgstein - Medfield MA, US
Assignee:
Acceleron Pharma Inc. - Cambridge MA
International Classification:
A61K 39/395
A61K 38/43
A61K 38/17
A61K 38/38
A61P 7/06
A61P 35/00
A61P 13/12
US Classification:
4241301, 514 12, 514 8, 4241781
Abstract:
In certain aspects, the present invention provides compositions and methods for increasing red blood cell and/or hemoglobin levels in vertebrates, including rodents and primates, and particularly in humans.

Antagonists Of Actriib And Uses For Increasing Red Blood Cell Levels

View page
US Patent:
20100028332, Feb 4, 2010
Filed:
Jun 26, 2009
Appl. No.:
12/459204
Inventors:
Matthew L. Sherman - Newton MA, US
Jasbir Seehra - Lexington MA, US
Niels Borgstein - Medfield MA, US
Assignee:
Acceleron Pharma Inc. - Cambridge MA
International Classification:
A61K 39/395
A61K 38/22
US Classification:
4241301, 514 12
Abstract:
In certain aspects, the present invention provides compositions and methods for increasing red blood cell and/or hemoglobin levels in vertebrates, including rodents and primates, and particularly in humans.

Antagonists Of Actriib And Uses For Increasing Red Blood Cell Levels

View page
US Patent:
20120003218, Jan 5, 2012
Filed:
Aug 25, 2011
Appl. No.:
13/218264
Inventors:
Matthew L. Sherman - Newton MA, US
Jasbir Seehra - Lexington MA, US
Niels Borgstein - Medfield MA, US
Assignee:
Acceleron Pharma Inc. - Cambridge MA
International Classification:
A61K 39/395
A61P 7/06
A61K 38/18
A61P 7/00
A61K 38/22
A61K 38/17
US Classification:
4241331, 4241721, 514 97, 514 89, 514 135
Abstract:
In certain aspects, the present invention provides compositions and methods for increasing red blood cell and/or hemoglobin levels in vertebrates, including rodents and primates, and particularly in humans.

Methods For Dosing An Actriib Antagonist And Monitoring Of Treated Patients

View page
US Patent:
20100008918, Jan 14, 2010
Filed:
Jun 26, 2009
Appl. No.:
12/459205
Inventors:
Matthew L. Sherman - Newton MA, US
Niels Borgstein - Medfield MA, US
Assignee:
Acceleron Pharma Inc. - Cambridge MA
International Classification:
A61K 39/395
C12Q 1/02
G01N 33/20
A61K 38/16
A61P 21/00
A61P 19/00
US Classification:
4241341, 435 29, 436 84, 4241391, 514 12
Abstract:
In certain aspects, the present invention provides methods for dosing a patient with an ActRIIb antagonist and methods for managing patients treated with an ActRIIb anatagonist. In certain aspects, the methods involve measuring one or more hematologic parameters in a patient.

Antagonists Of Activin-Actriia And Uses For Increasing Red Blood Cell Levels

View page
US Patent:
20220204576, Jun 30, 2022
Filed:
Aug 5, 2021
Appl. No.:
17/395372
Inventors:
- Cambridge MA, US
Jasbir Seehra - Cambridge MA, US
Niels Borgstein - Cambridge MA, US
International Classification:
C07K 14/495
A61K 38/17
A61K 38/22
C07K 14/71
C07K 16/00
C07K 16/22
Abstract:
In certain aspects, the present invention provides compositions and methods for increasing red blood cell and/or hemoglobin levels in vertebrates, including rodents and primates, and particularly in humans.

Antagonists Of Activin-Actriia And Uses For Increasing Red Blood Cell Levels

View page
US Patent:
20210355181, Nov 18, 2021
Filed:
Dec 23, 2020
Appl. No.:
17/132155
Inventors:
- Cambridge MA, US
Jasbir Seehra - Lexington MA, US
Niels Borgstein - Medfield MA, US
International Classification:
C07K 14/495
A61K 38/17
A61K 38/22
C07K 14/71
C07K 16/00
C07K 16/22
Abstract:
In certain aspects, the present invention provides compositions and methods for increasing red blood cell and/or hemoglobin levels in vertebrates, including rodents and primates, and particularly in humans.

Methods For Dosing An Activin-Actriia Antagonist And Monitoring Of Treated Patients

View page
US Patent:
20210038689, Feb 11, 2021
Filed:
Mar 17, 2020
Appl. No.:
16/821593
Inventors:
- Cambridge MA, US
Niels Borgstein - Medfield MA, US
International Classification:
A61K 38/17
C07K 14/72
G01N 33/72
G01N 33/80
G01N 33/90
A61P 7/06
A61P 19/00
C07K 14/475
A61K 38/22
Abstract:
In certain aspects, the present invention provides methods for dosing a patient with an activin-ActRIIa antagonist and methods for managing patients treated with an activin-ActRIIa antagonist. In certain aspects, the methods involve measuring one or more hematologic parameters in a patient.
Niels G Borgstein from Medfield, MA, age ~63 Get Report